HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Human apolipoprotein B48 receptor].

Abstract
Unique candidate receptor membrane binding proteins, MBP 200 and 235, were identified in human monocyte-macrophages. The MBP binds and internizes chylomicrons, triglyceride (TG)-rich VLDL, and VLDL devoid of apo E, but not acetyl LDL, via a domain in apo B48. The MBP is named apo B48 receptor because the receptor-binding domain is within apo B48. The apo B48 receptor differs from the scavenger receptor family and LDL receptor family because it does not bind acetyl LDL and it binds VLDL devoid of apo E by an apo E-independent mechanism. Immunohisto-chemical studies indicate colocalization of anti-apo B48 receptor Ab and monocyte-macrophage specific Ab in human atherosclerotic lesion foam cells. This suggests that apo B48 receptor may contribute to foam cell formation and atherosclerosis in abnormal state with elevated TG-rich lipoproteins.
AuthorsA Tanaka
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 57 Issue 12 Pg. 2711-6 (Dec 1999) ISSN: 0047-1852 [Print] Japan
PMID10638201 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Receptors, Lipoprotein
  • apolipoprotein B receptor
Topics
  • Arteriosclerosis (metabolism)
  • Humans
  • Receptors, Lipoprotein (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: